GKB Ophthalmics reported significantly increased net losses for FY25: ₹6.11 Cr standalone and ₹7.08 Cr consolidated, despite revenue growth.

Key financial ratios like Return on Networth and Debt-Equity worsened.

The company is focused on plastic lenses, investing in new machinery for export orders, and seeking a ₹7.50 Cr term loan for expansion.

Auditors highlighted concerns regarding electronic record-keeping, delayed statutory payments, and discrepancies in bank filings.

Shareholders will consider expanding borrowing limits and approving notable related-party transactions, including a subsidiary CEO's remuneration and revised transaction limits with Lensco.

The credit rating remains 'CRISIL D'.